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Abstract: In this work, we examined enhanced skin delivery of minoxidil applied in nanoemulsions
incorporating skin penetration enhancers. Aliquots of fully characterized oil-in-water nanoemulsions
(1 mL), containing minoxidil (2%) and the skin penetration enhancer oleic acid or eucalyptol as oil
phases, were applied to full-thickness excised human skin in Franz diffusion cells, while aqueous
solutions (1 mL) containing minoxidil were used as controls. Minoxidil in the stratum corneum (SC),
hair follicles, deeper skin layers, and flux through the skin over 24 h was determined, as well as
minoxidil solubility in the formulations and in the SC. The nanoemulsions significantly enhanced the
permeation of minoxidil through skin compared with control solutions. The eucalyptol formulations
(NE) promoted minoxidil retention in the SC and deeper skin layers more than did the oleic acid
formulations, while the oleic acid formulations (NO) gave the greatest hair follicle penetration.
Minoxidil maximum flux enhancement was associated with increases in both minoxidil SC solubility
and skin diffusivity in both nanoemulsion systems. The mechanism of enhancement appeared to be
driven largely by increased diffusivity, rather than increased partitioning into the stratum corneum,
supporting the concept of enhanced fluidity and disruption of stratum corneum lipids.
Keywords: nanoemulsion; stratum corneum; hair follicles; skin maximum flux; skin penetration
enhancers; oleic acid; eucalyptol
1. Introduction
The horny layer on the skin surface, the stratum corneum (SC), forms a significant barrier that
limits the absorption of substances that come in contact with it. However, despite the resistance
imposed by the SC, transcutaneous delivery of active substances for local or systemic effects continues
to attract interest. One strategy that is employed to reduce the impact of the SC barrier and enhance
skin absorption is the use of optimized colloidal formulations such as emulsions. Microemulsions
and nanoemulsions are commonly used in topical formulations applied to the skin as therapeutic,
cosmeceutical, cosmetic, and personal care products [1]. They offer high solubilization of actives
and the potential to manage delivery rates to the skin, in elegant products with good sensorial
characteristics. Micro- and nanoemulsions are thermodynamically stable, isotropic systems containing
water, oil, surfactants, and cosurfactants in specific ratios. They typically have droplets in the sub
100 micron range with low polydispersity (<10%), and can be designed to encapsulate and enhance the
skin delivery of a wide range of hydrophilic and lipophilic drugs [1]. The specific properties of micro-
and nanoemulsions, including their low interfacial tension and small droplet size, can be controlled
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with an appropriate mix of primary surfactant, such as a nonionic surfactant or lecithin; cosurfactant,
such as short or medium chain alcohols or polyglyceryl derivatives; and a high surfactant to oil ratio.
By using a combination of suitable excipients, penetration enhancement can be brought about
through different mechanisms. Commonly used oil phase components include fatty acids (e.g., oleic
acid), esters of fatty acids and alcohols (e.g., isopropyl myristate, isopropyl palmitate, ethyl oleate),
medium chain triglycerides, triacetin, and terpenes (e.g., limonene, menthol, cineole), many of which
have been shown to enhance percutaneous permeation with minimal irritation to the skin [2,3].
We chose eucalyptol for this work because it has been used previously as a penetration enhancer in
topical formulations with minimal skin irritation [4], although we note that adverse effects have been
reported. Vilaplana and Romaguera [5] reported a single case of contact dermatitis due to eucalyptol
in an anti-inflammatory cream, but pointed out that they had found only one previous reference
to a similar response, caused by eucalyptol derived from tea tree oil [6]. One way in which these
penetration enhancers affect skin is by disrupting the organization of SC lipids and increasing their
fluidity. This has the effect of decreasing the diffusional resistance to compounds [2,7,8]. Surfactants
and cosurfactants are also capable of performing this function, and may also increase drug solubility
within the stratum corneum.
Micro- and nanoemulsions may also promote skin absorption due to fluctuations in their oil–water
interface affecting the movement of the solute between their lipophilic and hydrophilic domains and
into the SC [9], increasing the solubilization capacity for both hydrophilic and lipophilic solutes, and
maintaining a constant supply of the solute in the external phase. As well as an ability to enhance
skin absorption, micro- and nanoemulsions may also act to reduce the irritant properties of certain
excipients. Thus, micro- and nanoemulsions may be regarded as superior vehicles for skin delivery
compared to conventional emulsions or gels, due to the interaction of their individual components
with the skin and their phase structure and particle size.
Under certain conditions, substances may enter the skin through appendages (hair follicles and
possibly sweat glands). The follicular infundibulum of the hair follicle provides an increased surface
area with an ever-decreasing SC barrier thickness with depth [10]. The dense network of blood
capillaries surrounding the hair follicles may also offer a mechanism for enhanced systemic absorption
for substances that penetrate into the follicles [11]. Consequently, hair follicles have potential as
a site for delivery of drugs into the viable skin layers, and for targeted delivery to treat conditions
related to the hair follicles such as acne and alopecia. The follicular penetration of dyes [12] and
nanoparticles [13] has been well studied, but relatively less has been done to examine follicular
delivery of therapeutic compounds [14]. Given the presence of sebum in hair follicles, it is likely that
the composition and physical properties of these formulations would facilitate transfollicular transport.
This makes nano- and microemulsion formulations an attractive option for targeted delivery to the
hair follicles for conditions such as acne and alopecia. Increased drug penetration of the lipophilic
compounds adapalene [15] and curcumin [16] into hair follicles from microemulsion formulations
has been demonstrated. Teichmann et al. showed that, in addition to increased deposition, the
microemulsion provided curcumin transport throughout the follicular infundibula, whereas with
a coarse emulsion/cream, curcumin delivery was limited to the follicular orifices.
This study aimed to determine the skin delivery and distribution of minoxidil (log P 1.24)
applied to human skin in oil-in-water (o/w) nanoemulsion formulations containing chemical
penetration enhancers with potentially different enhancement mechanisms (oleic acid and eucalyptol).
The determination of parameters such as skin permeation flux, diffusivity, partition coefficients,
and stratum corneum solubility provided insight into the mechanisms of permeation enhancement
occurring with these formulations. The formulations used here were previously developed and used
to enhance the permeation of naproxen and caffeine through excised human skin [17]. This work
expands those previous studies by examining minoxidil delivery into hair follicles. Differential tape
stripping followed by cyanoacrylate skin surface biopsy was performed, together with quantification
of minoxidil in skin layers, to determine the extent to which the skin and hair follicles could be targeted.
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2. Materials and Methods
2.1. Chemicals
Minoxidil, ethanol, oleic acid (OA), and eucalyptol (EU) were purchased from Sigma-Aldrich Pty.
Ltd. (Sydney, Australia). Volpo-N10 was obtained from Uniqema (Witton Centre, Witton Redcar, UK).
All chromatography reagents were analytical reagent grade.
2.2. Formulation Preparation and Characterization
The emulsion formulations containing surfactant, co-surfactant, and eucalyptol or oleic acid were
developed and characterized as previously described [17]. A ternary phase diagram was constructed
using the water titration technique to define the concentration ranges of components that produced
clear emulsions. Volpo-N10 (surfactant) was dissolved in ethanol (co-surfactant) in a 1:1 ratio, then
mixed with oleic acid or eucalyptol (oil phase) and phosphate buffered saline pH 7.4 (PBS: aqueous
phase) in a 0.6:1:1 ratio, followed by gentle mixing. The resulting nanoemulsions were clear at room
temperature. Minoxidil (2% w/w) was dissolved in the nanoemulsion and control solutions. This
concentration is used in commercial minoxidil products and was also used in previous skin permeation
studies from our laboratory [18]. The compositions of emulsions and control solutions are shown
in Table 1. The eucalyptol and oleic acid concentrations used in the emulsion formulations were
within the clear emulsion range (approximately 12–22%) shown in the previous study [17]. The
PEG-6000/water control solutions were used because these are inert vehicles that do not alter the skin
membrane properties and consequently cause no penetration enhancement.
Table 1. Compositions (% w/w) of control solutions (C1–C4) and nanoemulsion formulations with
penetration enhancers eucalyptol (NE1 and NE2) and oleic acid (NO1 and NO2). The concentration
of minoxidil in aqueous controls and nanoemulsions was 2% w/w, except in C1, which was
a saturated solution.





NE1 30.97 26.55 26.55 15.93
NE2 36.59 24.39 24.39 14.63
NO1 30.97 26.55 26.55 15.93
NO2 36.59 24.39 24.39 14.63
The droplet size distribution, refractive index, electrical conductivity, and viscosity of the
emulsions were determined at ambient temperature as previously described [17] and are shown
in Table 2.
Table 2. Physical and chemical characterization of the various nanoemulsion formulations defined
in Table 1.
PROPERTY NE1 NE2 NO1 NO2
Appearance Clear Clear Clear Clear
Viscosity (cp) 13.7 ± 4.5 15.1 ± 4.0 23.0 ± 4.7 28.3 ± 4.5
Conductivity (µS) 87.5 ± 2.2 91.3 ± 3.9 80.8 ± 8.2 84.5 ± 10.1
Refractive Index 1.38 1.37 1.38 1.37
Droplet size (nm) (emulsion only) 29.6 ± 3.1 19.5 ± 1.3 8.0 ± 0.5 12.4 ± 0.1
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2.3. Human Skin Preparation
Four skin samples were obtained with informed consent from female patients undergoing elective
abdominoplasty, and with approval from the University of Queensland Human Research Ethics
Committee (HREC Approval no. 2008001342, 25 October 2016). The procedures were conducted in
compliance with the guidelines of the National Health and Medical Research Council of Australia.
Full thickness skin was prepared by removal of subcutaneous fat by blunt dissection. Epidermal
membranes were prepared from full-thickness skin by immersion in water at 60 ◦C for 1 min, to allow
the epidermis to be teased away from the dermis [19]. Stratum corneum (SC) was prepared from the
epidermal membranes by trypsin digestion [20]. The epidermis was floated overnight on a solution of
0.01% trypsin in phosphate buffered saline at 37 ◦C. The digested viable epidermis was gently scraped
off with cotton buds and the remaining stratum corneum membrane was rinsed several times with
distilled water. The isolated stratum corneum membranes were dried with absorbent paper, placed
flat between parafilm sheets and covered with aluminum foil. All skin membranes were stored frozen
at −20 ◦C and used within one month.
2.4. Determination of Minoxidil Solubility in the Formulations (Sf) and in the Stratum Corneum (SSC)
The solubility of minoxidil in the formulation (Sf) was determined by adding minoxidil to 5 mL of
each nanoemulsion or control solution until an excess amount remained. The samples were incubated
in a water bath at 32 ◦C for 24 h with continuous agitation, then centrifuged at 4700 rpm for 10 min.
The supernatant was withdrawn and diluted to accurately quantify the minoxidil content by HPLC
(Shimadzu, Tokyo, Japan).
To determine the SC solubility of minoxidil from the various vehicles, preweighed discs of SC
(four replicates for each vehicle) were incubated in 1 mL saturated solutions of each vehicle at 32 ◦C
for 24 h [20]. The SC discs were then removed and blotted dry before being incubated with 1 mL of
70% ethanol/water for 24 h at 32 ◦C to enable complete extraction of the solutes. SSC was determined
from the amount recovered in the extraction fluid measured by HPLC divided by the thickness and
area of the SC [21].
2.5. In Vitro Skin Permeation Study
In vitro skin permeation studies were performed with full-thickness skin in Franz diffusion cells
with an effective diffusion area of 1.33 cm2 and approximately 3.4 mL receptor chamber capacity.
The skin was cut into discs and mounted between the donor and receptor compartment of the Franz
cell with the stratum corneum side facing the donor chamber. The receptor compartment containing
PBS (pH 7.4) was immersed in a water bath at 35 ± 0.5 ◦C. The donor solution consisted of 1 mL
of the nanoemulsion or control formulations, containing 2% w/w minoxidil (except C1, which was
a saturated solution). The donor compartment was covered with parafilm to prevent evaporation.
At predetermined time points, 200 µL of the receptor phase was withdrawn and replaced with an equal
volume of fresh PBS. The minoxidil content in all samples was determined by HPLC.
After Franz diffusion studies were completed, the skin in each cell was wiped with a cotton bud
to remove any remaining formulation and then subjected to tape stripping (20 times) by application
of adhesive tape (D-Squame tapes, CuDerm Corp., Dallas, TX, USA) to the exposed skin surface for
about 5 s, followed by careful removal. The tapes were placed into separate vials (groups of five) and
soaked overnight with 2 mL methanol before analysis by HPLC. The amount of absorbed minoxidil in
the tapes represented the amount of minoxidil deposited within the SC.
The technique of follicular casting, developed and validated by Lademann’s group [22] and
applied previously in our laboratory to quantify follicular delivery of minoxidil [18], was used here.
Following tape stripping, one drop of superglue (Loctite; Henkel, Düsseldorf, Germany) was placed
on a microscope slide, then pressed onto the surface of the stripped skin with light pressure for 15 min.
The slide was then peeled carefully from the skin. The superglue was dissolved by rubbing with
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acetone-soaked cotton buds (four times), and the cotton buds soaked overnight in 2 mL methanol prior
to analysis by HPLC.
After follicular casting, the skin was chopped into small pieces, homogenized, and soaked
overnight with 2 mL methanol under constant shaking and at room temperature before analysis
by HPLC.
2.6. HPLC Analysis of Minoxidil
Minoxidil in receptor fluid, SC, hair follicles, and skin layers was analyzed using a validated
HPLC assay. The HPLC system consisted of a Shimadzu SIL-20 a HT, a CBM-20A system controller,
an SPD-20A detector, an LC-20AD pump, and an auto injector. Isocratic separation of minoxidil
was performed on a Phenomenex Luna C18 5 µ (150 × 4.6 mm) column at ambient temperature
with a mobile phase of 60% of 0.01 M sodium dihydrogen phosphate (Na2H2PO4) buffer and 40%
acetonitrile v/v, containing 2.5 mM sodium dodecyl sulphate (SDS) and adjusted to pH 3 (1 mL/min
flow rate). The detection wavelength of minoxidil and its internal standard (propyl paraben) is 281 nm.
2.7. Data Analysis
The cumulative amount (Q, µg/cm2) of minoxidil penetrating through an area of 1.3 cm2 was
plotted against time (t). Steady-state flux JSS (µg/cm2/h) was determined from the slope of the linear
portion of the cumulative amount (Q) versus time plot.
The maximum flux (Jmax) that would be applicable to saturated solutions can be estimated
from the experimental steady state flux, corrected for the known solubility in the formulation, by
Equation (1) [21]:
Jmax = JSS Sf/Cf (1)
where Sf is the solubility in the formulation and Cf is the experimental concentration used.
The apparent diffusivity of minoxidil in the skin divided by path length (D*) was calculated from
the maximum flux and the solubility of minoxidil in the SC, according to Equation (2) [21]:
D* = Jmax/SSC (2)
where SSC is the experimentally determined solubility of minoxidil in the stratum corneum.
2.8. Statistical Analysis
All experiments were analyzed by one-way analysis of variance (ANOVA) with post-hoc
comparisons (Tukey) using GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA, USA); p < 0.05 was
considered to be significant.
Comparisons were made between the nanoemulsion formulations and controls, as well as between
the different nanoemulsion formulations, for the cumulative amount permeated at different time points
and the amount of minoxidil recovered following tape stripes, follicular casting, and skin extraction.
3. Results
3.1. In Vitro Permeation of Minoxidil across Full-Thickness Skin
The cumulative amounts (µg/cm2) of minoxidil permeated through full-thickness skin from each
nanoemulsion and control are shown in Figure 1. Minoxidil permeation from nanoemulsions was
greater than from control solutions. Minoxidil flux (Jss) over 24 h was in the order NE1 > NE2 > NO1
≥ NO2 > C4 > C1 = C2 = C3. The greatest flux was seen with formulations containing eucalyptol as
the oil phase, although all nanoemulsion formulations gave significantly greater fluxes than controls.
The 60% ethanol solution also showed enhanced minoxidil permeation compared with other controls.
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The solubility of minoxidil in the SC (Ssc) followed a similar pattern, although it was noted that, in
the controls, the ethanol/water solution (C4) showed the greatest solubility in the SC. Thus, the data
suggests that the nanoe ulsions provi e only a o est increase in inoxi il solubility in the S ,
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Formulation
JSS Jmax D* Sf SSC
(µg/cm2/h) (µg/cm2/h) (c /h*1E4) (mg/mL) (mg/mL)
C1 0.4 ± 0.1 0.4 ± 0.1 0.3 ± 0.1 15.5 2.3 13.2 ± 0.4
C2 0.2 ± 0.1 0.4 ± 0.1 0.3 ± 0.1 39.0 0.9 12.3 ± 4.3
C3 0.1 ± 0.0 0.4 ± 0.2 0.2 ± 0.2 73.0 ± 1.2 15.5 ± 0.4
C4 1.9 ± 0.1 3.3 ± 0.2 0.8 ± 0.0 34.7 ± 2.7 44.3 ± 4.6
NE1 18.1 ± 2.3 188.4 ± 23.4 13.8 ± 0.1 207.8 ± 1.6 136.1 ± 16.9
NE2 12.7 ± 1.9 179.9 ± 27.1 12.5 ± 1.8 283.4 ± 2.3 143.9 ± 13.4
NO1 6.2 ± 1.9 42.6 ± 12.9 5.7 ± 2.4 1 7.3 1.1 74.2 ± 8.0
NO2 6.9 ± 1.2 52.8 ± 9.0 7.0 ± 1.2 152.1 1.3 75.1 ± 5.7
The maximum flux of minoxidil (Jmax) for nanoemulsions (42.6 ± 12.9 to 188.4 ± 23.4 µg/cm2/h)
was substantially greater compared with all controls (0.4± 0.1 to 3.3± 0.2 µg/cm2/h). The diffusivity
D* of minoxidil was also one to two orders of magnitude greater from the nanoemulsions than from
the controls (Table 3). The increase in Jmax and D*, with only a modest increase in Ssc, suggests that
the mechanism of enhanced minoxidil penetration is primarily due to the reduction in SC barrier
resistance due to the oleic acid and eucalyptol.
To explore the different mechanisms of enhancement in the nanoemulsions, the enhancement
ratios of maximum flux, diffusivity, and SC–formulation partition coefficient compared to the ean
values for the controls (C1–C3) were plotted in Figure 2. It is evident that Jmax for minoxidil is greatly
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enhanced in the nanoemulsion formulations, while the enhancement with the ethanol/water solution
is significantly less (Figure 2a). A similar pattern is seen for diffusivity D*, whereas the effect on
partitioning from the formulation into the stratum corneum is small (Figure 2b). It is also evident from
Table 3 that Jmax was independent of minoxidil solubility in the vehicle, Sf, for all the control vehicles,
as would be expected for an inert vehicle that had no effect on the skin [21,23]. This was not the case
for the vehicles containing ethanol and penetration enhancers.
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3.3. Minoxidil Retention in the Stratum Corneum, Hair Follicles, and Skin Layers
inoxidil retention in the various skin co part ents (SC, hair follicles, and re aining skin
layers), as well as that permeated through skin into the receptor solution, is shown in Figure 3.
As there was an insignificant amount of minoxidil retained in the skin after topical application
in the three control vehicles C1–C3, we compared only control vehicle C4 (60% ethanol/water)
to the nanoemulsions in this section. The greatest minoxidil retention in the SC was from the
60% ethanol/water (C4) control solution (88.0 ± 3.5 µg/cm2), followed by the nanoemulsions
(37.0 ± 11.0–62.0 ± 15.0). The amounts of minoxidil retained in the deeper skin after 24 h from
nanoemulsion formulations were significantly greater than that from control C4 (p < 0.05) and were
in the order NE2 > NE1 > NO1 > NO2 (Figure 3). The minoxidil recovered from the hair follicles by
follicular casting is shown separately in Figure 4, as a percentage of the total applied dose. Follicular
delivery was greatest for the nanoemulsions, with the NO greater than the NE. There was a significant
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difference between follicular delivery from the 60% ethanol solution compared to that from the oleic
acid nanoemulsion NO1 (p < 0.05; 1-way ANOVA with post hoc comparison by Tukey’s test), but
other comparisons were not statistically significant. The actual amounts of minoxidil retained in the
follicles ranged from 7.5 µg/cm2 for the 60% ethanol solution (C4) to 22.5 µg/cm2 for the oleic acid
nanoemulsion (NO1).
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demonstrated that these nanoemulsion formulations gave increased skin delivery of caffeine and
naproxen. Three separate mechanisms with the potential to act synergistically may contribute to this
effect: (i) enhanced solubility of the drug in the applied nanoemulsions; (ii) increased uptake of the
vehicle carrying the drug into the SC; and (iii) a direct effect on the SC membrane properties, such as
increased fluidization of the SC lipids. Of particular interest in this study was the determination of
delivery via both the SC and the appendages, particularly given the relevance of follicular delivery
for minoxidil, a compound that acts on the hair follicles. Grice et al. [18] previously reported that the
deposition of minoxidil in appendages was of a similar magnitude to SC penetration following topical
application in simple vehicles, thus demonstrating the importance of the follicular route.
The solubility of minoxidil was substantially increased by the nanoemulsion formulations
containing a combination of oil phase containing penetration enhancers, surfactant, and cosurfactant,
and aqueous phase compared to all solvent mixture control solutions (for example, four- to eightfold
greater than the control mixture (C4) containing aqueous ethanol). This is consistent with literature
showing that terpene-based formulations provide effective solubilization of moderately lipophilic
compounds [26]. We also showed that the increased solubility in the nanoemulsion formulations
correlated directly with increased solubility of minoxidil in the stratum corneum, although this was
less pronounced when compared with the aqueous ethanol control (1.7- to 3.3-fold). Of the three
permeation enhancement mechanisms noted for caffeine and naproxen in our previous study of
these nanoemulsions [17], it is clear that for minoxidil the mechanisms of increased solubility in the
formulation and vehicle uptake into the SC also apply.
In this current work, we found that there was minimal minoxidil penetration for all formulations
up to 4 h, but after 4 h, penetration from the nanoemulsions and aqueous ethanol control increased
(Figure 1). Grice et al. [18] also reported a delayed response for minoxidil from solvent mixture
vehicles, which was explained in terms of delayed uptake of propylene glycol altering the membrane
properties to enhance minoxidil permeation, although the delay was considerably longer in that case.
In this work, we found that very little minoxidil permeated though the skin into the receptor fluid
by 8 h. Similar results were obtained by Mura et al., who showed only small amounts reaching the
epidermis after 8 h [27]. In the present study, we used ethanol as a co-surfactant. As a result of the
evaporation of ethanol, the viscosity of the formulations could increase, thereby reducing the solubility
of minoxidil in the skin, as well as its thermodynamic activity in the vehicle, leading to delayed skin
permeation [28,29].
To further explore the mechanisms of enhanced skin permeation, we determined Jmax, the
maximum (or saturated) flux, as it is well recognized that Jmax is independent of the vehicle, but
depends solely on the thermodynamic activity of the solute in the vehicle, provided the vehicle or
solute does not alter the membrane properties [21,23,30]. It is evident that the control vehicles all had
similarly low minoxidil Jmax values, indicating that the control vehicles, with a range of minoxidil
solubilities, did not affect skin permeation. This is consistent with the report of Twist and Zatz [31], who
applied methyl paraben with a range of solubilities in different vehicles to synthetic membranes and
showed the same methyl paraben flux in each case, regardless of its vehicle solubility. In contrast, we
found that the Jmax values for the nanoemulsions were much greater than for controls (Figure 2a). This
is consistent with the notion that they have enhanced skin permeability by altering the SC membrane
properties. The nanoemulsions were also associated with excellent SC solubility (Table 3). One of the
mechanisms by which enhancers such as eucalyptol and oleic acid act is known to involve SC lipid
dissolution [32]. In the case of the nanoemulsions used in this study, they appear to be promoting
minoxidil penetration by the third mechanism, namely, modification of the SC properties.
An important mechanistic outcome of this work is the strong dependence of Jmax on diffusivity,
D*, for the enhancer formulations (Figure 2). Overall, diffusivity will be independent from solute
lipophilicity if the vehicles do not affect the SC [23,33]. Nonetheless, different effects may be seen when
the vehicle affects the SC, as previously seen for hydrophilic phenols which exhibited more pronounced
penetration enhancement relative to more lipophilic phenols applied in isopropyl myristate (IPM) [23].
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IPM has a high affinity for skin and can disrupt the SC intercellular lipid matrix [23] and so may
be expected to also affect minoxidil (log P 1.24), consistent with the diffusivity enhancement by
nanoemulsions seen here.
Oleic acid and eucalyptol are well-established penetration enhancers. A unique feature of OA is
its cis double bond at C9 which causes a kink in the alkyl chain and disturbs the SC lipid bilayers [34].
EU also acts by disrupting the SC lipid organization and increasing fluidization which leads to
increased drug diffusivity [35]. Obata et al. [36] claimed that ethanol causes greater enhancement in
combination with hydrophilic terpenes such as eucalyptol, compared to mixtures containing lipophilic
terpenes [37,38]. Here, the EU nanoemulsions, also containing ethanol, caused the greatest penetration
of minoxidil. This is also consistent with the enhanced permeation of curcumin from EU-containing
microemulsions reported by Liu et al. (2010), who proposed that eucalyptol enters the skin in monomer
form and increases drug solubility in the skin, increases partitioning of drugs into the skin, and creates
high drug concentrations in the upper layers of the skin [39]. Our results showing the greatest SC
solubility with EU nanoemulsions are consistent with this mechanism.
The OA nanoemulsions showed greater minoxidil retention in the hair follicles than did the EU
formulations. This enhanced follicular penetration is likely associated with the minoxidil solubility in
the nanoemulsions and the compatibility of the nanoemulsions with the lipophilic sebum environment
of the sebum [40]. In contrast, EU nanoemulsions showed greater retention of minoxidil in the SC.
These results suggest that the mechanism of drug transport across skin depends on the composition of
the formulation and the solute used.
5. Conclusions
In conclusion, the nanoemulsion systems in this study significantly enhanced the permeation
of minoxidil through full-thickness human skin. Both nanoemulsions increased the diffusivity of
minoxidil and its solubility in the stratum corneum. While the mechanism of penetration enhancement
has been suggested to involve increases in both partitioning and diffusivity, depending on the
deliverable and the vehicle, in this study, the influence of diffusivity far outweighed that of increased
partitioning. Furthermore, the enhanced minoxidil deposition seen in hair follicles in this study
suggests that nanoemulsions may be suitable vehicles to deliver substances into appendages for
therapeutic purposes. Further formulation optimization is likely to result in greater drug delivery
by this route. Work is currently in progress to characterize the skin irritancy potential of these
nanoemulsion formulations containing penetration enhancers.
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